Literature DB >> 26941445

New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018: Statement of the Gynecology Oncology Working Group (AGO).

P Hillemanns1, P Mallmann2, M W Beckmann3.   

Abstract

The Gynecology Oncology Working Group (AGO e. V.) unequivocally welcomes the decision taken by the German Federal Joint Commission (Gemeinsamer Bundesausschuss, G-BA) on March 19, 2015 regarding screening for cervical cancer. AGO is convinced that, in view of recent medical advances, this evidence-based decision will improve screening for cervical cancer.

Entities:  

Keywords:  HPV screening; cervical cancer screening in Germany; national screening program

Year:  2016        PMID： 26941445      PMCID： PMC4771500          DOI： 10.1055/s-0035-1568209

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN： 0016-5751            Impact factor:   2.915


  2 in total

1.  Cervical cancer screening in Germany: group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data.

Authors:  Siegfried Geyer; Jelena Jaunzeme; Peter Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2014-08-20       Impact factor: 2.344

2.  Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.

Authors:  Karl Ulrich Petry; Alexander Luyten; Annika Justus; Angelika Iftner; Sarah Strehlke; Axel Reinecke-Lüthge; Elisabeth Grunwald; Renate Schulze-Rath; Thomas Iftner
Journal:  BMC Infect Dis       Date:  2013-03-13       Impact factor: 3.090
  2 in total
  1 in total

1.  Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment.

Authors:  Frederik A Stuebs; Martin C Koch; Anna K Dietl; Werner Adler; Carol Geppert; Arndt Hartmann; Antje Knöll; Matthias W Beckmann; Grit Mehlhorn; Carla E Schulmeyer; Paul Gass
Journal:  Diagnostics (Basel)       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.